Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Greer

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|April 1, 1988
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serumR T Means, S B Krantz, E N Dessypris, et al.
Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.
Cancer|January 1, 1989
Peripheral T-cell lymphomaJ O Armitage, J P Greer, A M Levine, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Bone Marrow Transplantation|September 6, 2001
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysisM Vusirikala, S N Wolff, R S Stein, et al.
Hematological Oncology|July 1, 1990
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell processJ P Greer, K E Salhany, J B Cousar, et al.
Leukemia|February 1, 1997
High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemiaJ A Whitlock, R J Wells, J D Hord, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Bone Marrow Transplantation|June 5, 2012
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markersS M Sengsayadeth, M Jagasia, B G Engelhardt, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|April 1, 1988
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serumR T Means, S B Krantz, E N Dessypris, et al.
Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.
Cancer|January 1, 1989
Peripheral T-cell lymphomaJ O Armitage, J P Greer, A M Levine, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Bone Marrow Transplantation|September 6, 2001
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysisM Vusirikala, S N Wolff, R S Stein, et al.
Hematological Oncology|July 1, 1990
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell processJ P Greer, K E Salhany, J B Cousar, et al.
Leukemia|February 1, 1997
High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemiaJ A Whitlock, R J Wells, J D Hord, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Bone Marrow Transplantation|June 5, 2012
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markersS M Sengsayadeth, M Jagasia, B G Engelhardt, et al.
Pageof 9